Rani AbZ en es it fr

Rani AbZ Brand names, Rani AbZ Analogs

Rani AbZ Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Rani AbZ Chemical_Formula


Rani AbZ RX_link


Rani AbZ fda sheet

Rani_AbZ FDA

Rani AbZ msds (material safety sheet)


Rani AbZ Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Rani AbZ Molecular Weight

314.405 g/mol

Rani AbZ Melting Point

69-70 oC

Rani AbZ H2O Solubility

24.7 mg/mL

Rani AbZ State


Rani AbZ LogP


Rani AbZ Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Rani AbZ Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Rani AbZ Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Rani AbZ Absorption

Approximately 50% bioavailability orally.

Rani AbZ side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Rani AbZ Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Rani AbZ Organisms Affected

Humans and other mammals